The FDA Has Ended Required Blood Monitoring for Clozapine Use-Will This Impact the Management of Parkinson's Disease Psychosis? Weintraub D, Schoen I. Mov Disord 2025 Jul 15. doi: 10.1002/mds.30295.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Weintraub D, Schoen I. The FDA Has Ended Required Blood Monitoring for Clozapine Use-Will This Impact the Management of Parkinson's Disease Psychosis? Mov Disord 2025 Jul 15. doi: 10.1002/mds.30295.
PMID: 40662618